{
  "profile_url": "https://www.moffitt.org/research-science/researchers/jose-alejandro-guevara",
  "last_updated": "2025-10-21T16:39:55.031165",
  "researcher_id": "29147",
  "degrees": [
    "MD",
    "PhD"
  ],
  "title": "",
  "primary_program": "Immunology",
  "research_program": "Immuno-Oncology Program",
  "overview": "Dr. Guevara-Pati\u00f1o\u2019s research is focused on identifying signaling cues that can be exploited for the benefit of cancer patients receiving T cell-based immunotherapy, by deeply understanding the immune fertile conditions that are necessary to generate robust anti-tumor T cell responses. Jos\u00e9 Alejandro is specifically interested in understanding the role of RPS6 as well as the effects of tumor-related hypoxia on anti-tumor T cells. In addition, he is implementing machine learning approaches for the development of immunological predictive biomarkers that will permit the stratification of cancer patients receiving immunotherapies.",
  "research_interests": [
    "Dr. Guevara-Pati\u00f1o\u2019s research is focused on identifying signaling cues that can be exploited for the benefit of cancer patients receiving T cell-based immunotherapy, by deeply understanding the immune fertile conditions that are necessary to generate robust anti-tumor T cell responses. Jos\u00e9 Alejandro is specifically interested in understanding the role of RPS6 as well as the effects of tumor-related hypoxia on anti-tumor T cells. In addition, he is implementing machine learning approaches for the development of immunological predictive biomarkers that will permit the stratification of cancer patients receiving immunotherapies.\n  *"
  ],
  "associations": [
    "Immunology",
    "Immuno-Oncology Program"
  ],
  "education": [
    {
      "type": "Graduate",
      "institution": "University College London, National Institute for Medical Research, UK, PhD"
    },
    {
      "type": "Medical School",
      "institution": "Universidad Central de Venezuela",
      "degree": "MD"
    },
    {
      "type": "Fellowship",
      "institution": "Memorial Sloan-Kettering Cancer Center",
      "specialty": "T Cell Development and tumor Immunology"
    }
  ],
  "publications": [
    {
      "title": "Clinical significance of peripheral T-cell repertoire in head and neck squamous cell carcinoma treated with cetuximab and nivolumab",
      "pubmed_id": "40056190",
      "pmc_id": "PMC11890688",
      "year": "2025",
      "publication_date": "2025 Mar",
      "authors": "Wang X, Li T, Slebos RJC, Chaudhary R, Guevara-Patino JA, Bonomi M, Saba NF, Chung CH",
      "journal": "Cancer Immunol Immun"
    },
    {
      "title": "PV-10 triggers immunogenic cell death in head and neck squamous cell carcinoma via endoplasmic reticulum stress and apoptosis",
      "pubmed_id": "40552938",
      "pmc_id": "PMC12327362",
      "year": "2025",
      "publication_date": "2025 Jun",
      "authors": "Thatikonda S, Chaudhary R, Meshkovska Y, Biernacki M, Slebos RJC, Song X, Hall MS, Lilley K, Pilon-Thomas S, Guevara-Patino JA, Spiess PE, Chahoud J, Amelio AL, Wachter EA, Rodrigues D, Chung CH",
      "journal": "Mol Cancer Ther"
    },
    {
      "title": "Effector T cells under hypoxia have an altered transcriptome similar to tumor-stressed T cells found in non-responsive melanoma patients",
      "pubmed_id": "40010774",
      "year": "2025",
      "publication_date": "2025 Feb",
      "authors": "Nagy MZ, Plaza-Rojas LB, Boucher JC, Kostenko E, Austin AL, Tarhini AA, Chen Z, Du D, Ojwang' AME, Davis J, Obermayer A, Rejniak KA, Shaw TI, Guevara-Patino JA",
      "journal": "J Immunother Cancer"
    },
    {
      "title": "NKG2D receptor signaling shapes T cell thymic education",
      "pubmed_id": "37949818",
      "year": "2024",
      "publication_date": "2024 Jan",
      "authors": "Perez C, Plaza-Rojas L, Boucher JC, Nagy MZ, Kostenko E, Prajapati K, Burke B, Reyes MD, Austin AL, Zhang S, Le PT, Guevara-Patino JA",
      "journal": "J Leukoc Biol"
    },
    {
      "title": "EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma",
      "pubmed_id": "37377902",
      "pmc_id": "PMC10202124",
      "year": "2023",
      "publication_date": "2023 May",
      "authors": "Chaudhary R, Slebos RJC, Noel LC, Song F, Poole MI, Hoening DS, Hernandez-Prera JC, Conejo-Garcia JR, Guevara-Patino JA, Wang X, Xie M, Tan AC, Chung CH",
      "journal": "Cancer Res Commun"
    },
    {
      "title": "NKG2D signaling shifts the balance of CD8 T cells from single cytokine- to polycytokine-producing effector cells",
      "pubmed_id": "36634520",
      "pmc_id": "PMC9992161",
      "year": "2023",
      "publication_date": "2023 Mar",
      "authors": "Kohlhapp FJ, O'Sullivan JA, Moore TV, Zloza A, Guevara-Pati\u00f1o JA",
      "journal": "Mol Immunol"
    },
    {
      "title": "Emerging monoclonal antibody therapies in the treatment of metastatic urothelial carcinoma",
      "pubmed_id": "36882977",
      "year": "2023",
      "publication_date": "2023 Mar",
      "authors": "Jain RK, Singh AM, Wang X, Guevara-Pati\u00f1o JA, Sonpavde G",
      "journal": "Expert Opin Emerg Drugs"
    },
    {
      "title": "Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer",
      "pubmed_id": "37433716",
      "pmc_id": "PMC10347455",
      "year": "2023",
      "publication_date": "2023 Jul",
      "authors": "Jhawar SR, Wang SJ, Thandoni A, Bommareddy PK, Newman JH, Marzo AL, Kuzel TM, Gupta V, Reiser J, Daniels P, Schiff D, Mitchell D, LeBoeuf NR, Simmons C, Goyal S, Lasfar A, Guevara-Patino JA, Haffty BG, Kaufman HL, Silk AW, Zloza A",
      "journal": "J Immunother Cancer"
    },
    {
      "title": "Antibody-Drug Conjugates in the Treatment of Urothelial Cancer",
      "pubmed_id": "37256534",
      "year": "2023",
      "publication_date": "2023 Jul",
      "authors": "Singh AM, Guevara-Patino JA, Wang X, Li R, Sonpavde G, Jain RK",
      "journal": "BioDrugs"
    },
    {
      "title": "Memory Precursors and Short-Lived Effector T cell Subsets Have Different Sensitivities to TGF\u03b2",
      "pubmed_id": "36835342",
      "pmc_id": "PMC9966622",
      "year": "2023",
      "publication_date": "2023 Feb",
      "authors": "O'Sullivan JA, Kohlhapp FJ, Zloza A, Plaza-Rojas L, Burke B, Dulin NO, Guevara-Pati\u00f1o JA",
      "journal": "Int J Mol Sci"
    }
  ],
  "grants": [
    {
      "description": "Title: Development and Implementation of Exhaustion Resistant CAR-T Cell Against Melanoma  \nAward Number:   \nSponsor: VOLO FOUNDATION  \nGuevara, J. (PD/PI)",
      "title": "Development and Implementation of Exhaustion Resistant CAR-T Cell Against Melanoma",
      "award_number": "",
      "sponsor": "VOLO FOUNDATION",
      "investigators": [
        {
          "name": "Guevara, J.",
          "role": "PD/PI"
        }
      ]
    },
    {
      "description": "Title: Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells  \nAward Number: 5R01CA250514-05  \nSponsor: National Cancer Institute (NCI)  \nGuevara, J. (PD/PI)",
      "title": "Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells",
      "award_number": "5R01CA250514-05",
      "sponsor": "National Cancer Institute (NCI)",
      "source": "NCI",
      "investigators": [
        {
          "name": "Guevara, J.",
          "role": "PD/PI"
        }
      ]
    },
    {
      "description": "Title: Exploratory Study of T Cell Skin Trafficking and the Role of NKG2D Signaling; Implications in Vitiligo and Melanoma  \nAward Number: 1R21AR081633-01A1  \nSponsor: National Institute on Aging (NIA)  \nGuevara, J. (PD/PI)",
      "title": "Exploratory Study of T Cell Skin Trafficking and the Role of NKG2D Signaling; Implications in Vitiligo and Melanoma",
      "award_number": "1R21AR081633-01A1",
      "sponsor": "National Institute on Aging (NIA)",
      "investigators": [
        {
          "name": "Guevara, J.",
          "role": "PD/PI"
        }
      ]
    },
    {
      "description": "Title: CD3z-Independent Signaling Module for CAR-T Cell Therapies Against Solid Cancer  \nAward Number: 23B08  \nSponsor: Florida Department of Health  \nGuevara, J. (PD/PI)",
      "title": "CD3z-Independent Signaling Module for CAR-T Cell Therapies Against Solid Cancer",
      "award_number": "23B08",
      "sponsor": "Florida Department of Health",
      "investigators": [
        {
          "name": "Guevara, J.",
          "role": "PD/PI"
        }
      ]
    }
  ],
  "photo_url": "https://www.moffitt.org/globalassets/images/researchers_bio/GuevaraJoseAlejandro_29147.jpg",
  "contact": {
    "contact_url": "https://eforms.moffitt.org/ContactResearchersForm?PERID=29147"
  },
  "content_hash": "d14fdb2e1cf67fae97a61e9e3449235779d71c9a696a1ebaf2d901ecc5b0cc35",
  "researcher_name": "Jose Alejandro Guevara",
  "department": "Immunology"
}